No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

• Үндсэн зохиолчид: Abdi Naficy (Зохиогч), Adrienne Kuxhausen (Зохиогч), Harry Seifert (Зохиогч), Andrew Hastie (Зохиогч), Brett Leav (Зохиогч), Jacqueline Miller (Зохиогч), Kate Anteyi (Зохиогч), Agnes Mwakingwe-Omari (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

ABSTRACTThe objective of the study was to assess the safety and immunogenicity of mRNA-1273 COVID-19 booster vaccination when co-administered with an egg-based standard dose seasonal quadrivalent influenza vaccine (QIV). This was a phase 3, randomized, open-label study. Eligible adults aged ≥ 18 yea...